AVENUE THERAPEUTICS, INC. Annual Share-based Payment Arrangement, Expense in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Avenue Therapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2015 to 2024.
  • Avenue Therapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2024 was $522K, a 70% increase year-over-year.
  • Avenue Therapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2024 was $1.24M, a 36.4% increase year-over-year.
  • Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $1.24M, a 36.4% increase from 2023.
  • Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $906K, a 39.6% increase from 2022.
  • Avenue Therapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $649K.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.24M +$330K +36.4% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-31
2023 $906K +$257K +39.6% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-31
2022 $649K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-18
2017 $200K -$100K -33.3% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-01
2016 $300K +$200K +200% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-01
2015 $100K Feb 9, 2015 Dec 31, 2015 10-K 2018-03-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.